We are live on ! Find out more
Robert Olstein

Robert Olstein Olstein Capital Management

AUM $458M Turnover 5.83%
1-Year Est. Return 6.27%
 

Robert Olstein is the founder of Olstein Capital Management and a long-time advocate of forensic accounting and quality-of-earnings analysis in equity investing. His process looks beyond headline multiples to assess earnings sustainability and balance-sheet risk. Olstein’s work is frequently referenced by investors who prioritize accounting diligence.

This Fund
S&P 500
This Quarter Est. Return
+4.49%
1 Year Est. Return
+6.27%
3 Year Est. Return
+16.62%
5 Year Est. Return
+3.39%
10 Year Est. Return
+96.48%
AUM
$775M
AUM Growth
+$15.6M
Cap. Flow
-$20.8M
Cap. Flow %
-2.68%
Top 10 Hldgs %
19.21%
Holding
115
New
9
Increased
31
Reduced
50
Closed
8
Avg Time Held
2 years
Top 10 Avg Time Held
0.7 years
Top 20 Avg Time Held
1.3 years

Top Buys

Rank Stock Value
1
ZBH icon
Zimmer Biomet
ZBH
+$11.7M
2
WOOF icon
VCA Inc.
WOOF
+$7.98M
3
VWR
VWR Corporation
VWR
+$7.02M
4
NWL icon
Newell Brands
NWL
+$6.73M
5
SKX icon
Skechers
SKX
+$6.31M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 23.69%
2 Industrials 17.87%
3 Healthcare 16.25%
4 Financials 16.04%
5 Technology 13.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ZBH icon
1
Zimmer Biomet
ZBH
$18.1B
$17.7M 2.29%
176,980
+109,000
+160% +$11.7M
2013 Q2
14 quarters
LM
2
DELISTED
Legg Mason, Inc.
LM
$16.9M 2.18%
564,550
– –
2013 Q2
14 quarters
ZBRA icon
3
Zebra Technologies
ZBRA
$17.8B
$16.8M 2.17%
195,879
-59,771
-23% -$4.43M
2015 Q3
5 quarters
VSI
4
DELISTED
Vitamin Shoppe Inc.
VSI
$15.5M 2%
652,795
+65,050
+11% +$1.67M
2013 Q2
14 quarters
BBBY
5
DELISTED
Bed Bath & Beyond Inc
BBBY
$14.8M 1.91%
364,480
+23,925
+7% +$1.04M
2013 Q2
14 quarters
PDCO icon
6
DELISTED
Patterson Companies, Inc.
PDCO
$14.5M 1.87%
352,605
+78,690
+29% +$3.39M
2014 Q3
9 quarters
OI icon
7
O-I Glass
OI
$907M
$13.8M 1.78%
792,415
-27,070
-3% -$492K
2014 Q4
8 quarters
KEYS icon
8
Keysight
KEYS
$57.2B
$13.6M 1.76%
372,115
-125,860
-25% -$4.34M
2015 Q1
7 quarters
JNS
9
DELISTED
Janus Capital Group Inc
JNS
$12.7M 1.63%
954,845
-24,675
-3% -$339K
2013 Q2
14 quarters
DDS icon
10
Dillards
DDS
$10.4B
$12.7M 1.63%
201,995
-16,580
-8% -$1.09M
2013 Q3
13 quarters
SAVE icon
11
DELISTED
Spirit Airlines, Inc.
SAVE
$12.1M 1.56%
209,090
-162,000
-44% -$8.35M
2013 Q2
14 quarters
GBX icon
12
The Greenbrier Companies
GBX
$1.19B
$11.8M 1.52%
283,550
-137,740
-33% -$5.14M
2014 Q2
10 quarters
ORCL icon
13
Oracle
ORCL
$393B
$11.7M 1.51%
305,000
+33,000
+12% +$1.29M
2013 Q4
12 quarters
DBI icon
14
Designer Brands
DBI
$309M
$11.7M 1.51%
515,480
+20,000
+4% +$454K
2014 Q3
9 quarters
CFG icon
15
Citizens Financial Group
CFG
$26.4B
$11.4M 1.47%
318,970
-282,570
-47% -$8.56M
2015 Q1
7 quarters
IVZ icon
16
Invesco
IVZ
$12.5B
$11.2M 1.45%
369,432
-34,000
-8% -$1.05M
2014 Q1
11 quarters
CVS icon
17
CVS Health
CVS
$119B
$11M 1.42%
140,000
+32,000
+30% +$2.59M
2014 Q1
11 quarters
MSFT icon
18
Microsoft
MSFT
$3.96T
$11M 1.42%
177,000
– –
2013 Q2
14 quarters
VWR
19
DELISTED
VWR Corporation
VWR
$10.8M 1.4%
432,387
+264,148
+157% +$7.02M
2016 Q3
1 quarter
RRX icon
20
Regal Rexnord
RRX
$10.5B
$10.7M 1.38%
154,787
-58,113
-27% -$3.85M
2013 Q2
14 quarters
EBAY icon
21
eBay
EBAY
$53.6B
$10.6M 1.37%
358,000
+71,000
+25% +$2.1M
2013 Q2
14 quarters
GM icon
22
General Motors
GM
$72.6B
$10.5M 1.35%
300,000
-10,000
-3% -$336K
2013 Q2
14 quarters
WCC icon
23
WESCO International
WCC
$16.7B
$10.4M 1.35%
156,760
-53,590
-25% -$3.4M
2014 Q2
10 quarters
CRL icon
24
Charles River Laboratories
CRL
$14.3B
$10.4M 1.34%
136,035
+50,410
+59% +$3.83M
2016 Q1
3 quarters
DISCK
25
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$10.3M 1.33%
386,040
– –
2014 Q4
8 quarters

Similar funds

Robert Olstein's Q4 2016 Portfolio in Review

As of Q4 2016, Robert Olstein held 115 positions worth $775M, up 2.1% from $760M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Robert Olstein's Q4 2016 filing shows 9 new, 31 increased, 50 reduced and 8 closed positions. Its largest new stake was VCA Inc.: 122,150 shares worth $8.39M. The largest sale was Harman International Industries, an estimated $10.2M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 24% of assets, up from 22% a quarter earlier, followed by Industrials and Healthcare.

  • Robert Olstein's largest Q4 2016 buy was VCA Inc.: 122,150 shares worth $8.39M.
  • Robert Olstein added most to Zimmer Biomet in Q4 2016, an estimated $11.7M increase.
  • Robert Olstein's biggest Q4 2016 reduction was Harman International Industries, cutting an estimated $10.2M.
  • Robert Olstein fully exited Oshkosh in Q4 2016, selling an estimated $6.94M.
  • Robert Olstein's ten largest holdings make up 19% of its $775M portfolio in Q4 2016.
  • Robert Olstein opened 9 new positions and closed 8 in Q4 2016.
  • Robert Olstein's portfolio value rose 2.1% quarter-over-quarter to $775M.

Based on Olstein Capital Management's 13F filing for Q4 2016, filed 9 Feb 2017.